137 related articles for article (PubMed ID: 20533828)
1. New role for LEKTI in skin barrier formation: label-free quantitative proteomic identification of caspase 14 as a novel target for the protease inhibitor LEKTI.
Bennett K; Callard R; Heywood W; Harper J; Jayakumar A; Clayman GL; Di WL; Mills K
J Proteome Res; 2010 Aug; 9(8):4289-94. PubMed ID: 20533828
[TBL] [Abstract][Full Text] [Related]
2. LEKTI domain 15 is a functional Kazal-type proteinase inhibitor.
Vitzithum K; Lauber T; Kreutzmann P; Schulz A; Sommerhoff CP; Rösch P; Marx UC
Protein Expr Purif; 2008 Jan; 57(1):45-56. PubMed ID: 17936012
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of human kallikreins 5 and 7 by the serine protease inhibitor lympho-epithelial Kazal-type inhibitor (LEKTI).
Schechter NM; Choi EJ; Wang ZM; Hanakawa Y; Stanley JR; Kang Y; Clayman GL; Jayakumar A
Biol Chem; 2005 Nov; 386(11):1173-84. PubMed ID: 16307483
[TBL] [Abstract][Full Text] [Related]
4. The identification of a new role for LEKTI in the skin: The use of protein 'bait' arrays to detect defective trafficking of dermcidin in the skin of patients with Netherton syndrome.
Bennett K; Heywood W; Di WL; Harper J; Clayman GL; Jayakumar A; Callard R; Mills K
J Proteomics; 2012 Jul; 75(13):3925-37. PubMed ID: 22588119
[TBL] [Abstract][Full Text] [Related]
5. LEKTI-1 in sickness and in health.
Roelandt T; Thys B; Heughebaert C; De Vroede A; De Paepe K; Roseeuw D; Rombaut B; Hachem JP
Int J Cosmet Sci; 2009 Aug; 31(4):247-54. PubMed ID: 19467033
[TBL] [Abstract][Full Text] [Related]
6. Proteolytic activation cascade of the Netherton syndrome-defective protein, LEKTI, in the epidermis: implications for skin homeostasis.
Fortugno P; Bresciani A; Paolini C; Pazzagli C; El Hachem M; D'Alessio M; Zambruno G
J Invest Dermatol; 2011 Nov; 131(11):2223-32. PubMed ID: 21697885
[TBL] [Abstract][Full Text] [Related]
7. The 420K LEKTI variant alters LEKTI proteolytic activation and results in protease deregulation: implications for atopic dermatitis.
Fortugno P; Furio L; Teson M; Berretti M; El Hachem M; Zambruno G; Hovnanian A; D'Alessio M
Hum Mol Genet; 2012 Oct; 21(19):4187-200. PubMed ID: 22730493
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of kallikrein-related peptidases by the serine protease inhibitor of Kazal-type 6.
Kantyka T; Fischer J; Wu Z; Declercq W; Reiss K; Schröder JM; Meyer-Hoffert U
Peptides; 2011 Jun; 32(6):1187-92. PubMed ID: 21439340
[TBL] [Abstract][Full Text] [Related]
9. Expression of LEKTI domains 6-9' in the baculovirus expression system: recombinant LEKTI domains 6-9' inhibit trypsin and subtilisin A.
Jayakumar A; Kang Y; Mitsudo K; Henderson Y; Frederick MJ; Wang M; El-Naggar AK; Marx UC; Briggs K; Clayman GL
Protein Expr Purif; 2004 May; 35(1):93-101. PubMed ID: 15039071
[TBL] [Abstract][Full Text] [Related]
10. hK5 and hK7, two serine proteinases abundant in human skin, are inhibited by LEKTI domain 6.
Egelrud T; Brattsand M; Kreutzmann P; Walden M; Vitzithum K; Marx UC; Forssmann WG; Mägert HJ
Br J Dermatol; 2005 Dec; 153(6):1200-3. PubMed ID: 16307658
[TBL] [Abstract][Full Text] [Related]
11. Correlation between SPINK5 gene mutations and clinical manifestations in Netherton syndrome patients.
Komatsu N; Saijoh K; Jayakumar A; Clayman GL; Tohyama M; Suga Y; Mizuno Y; Tsukamoto K; Taniuchi K; Takehara K; Diamandis EP
J Invest Dermatol; 2008 May; 128(5):1148-59. PubMed ID: 17989726
[TBL] [Abstract][Full Text] [Related]
12. Identification of lympho-epithelial Kazal-type inhibitor 2 in human skin as a kallikrein-related peptidase 5-specific protease inhibitor.
Meyer-Hoffert U; Wu Z; Schröder JM
PLoS One; 2009; 4(2):e4372. PubMed ID: 19190773
[TBL] [Abstract][Full Text] [Related]
13. Recombinant production, purification and biochemical characterization of domain 6 of LEKTI: a temporary Kazal-type-related serine proteinase inhibitor.
Kreutzmann P; Schulz A; Ständker L; Forssmann WG; Mägert HJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Apr; 803(1):75-81. PubMed ID: 15026000
[TBL] [Abstract][Full Text] [Related]
14. Reddish, scaly, and itchy: how proteases and their inhibitors contribute to inflammatory skin diseases.
Meyer-Hoffert U
Arch Immunol Ther Exp (Warsz); 2009; 57(5):345-54. PubMed ID: 19688185
[TBL] [Abstract][Full Text] [Related]
15. rAAV2-mediated restoration of LEKTI in LEKTI-deficient cells from Netherton patients.
Roedl D; Oji V; Buters JT; Behrendt H; Braun-Falco M
J Dermatol Sci; 2011 Mar; 61(3):194-8. PubMed ID: 21251800
[TBL] [Abstract][Full Text] [Related]
16. Expression and regulation of murine SPINK12, a potential orthologue of human LEKTI2.
Reiss K; Meyer-Hoffert U; Fischer J; Sperrhacke M; Wu Z; Dimitrieva O; Krenek P; Suchanova S; Buryova H; Brauer R; Sedlacek R
Exp Dermatol; 2011 Nov; 20(11):905-10. PubMed ID: 21899598
[TBL] [Abstract][Full Text] [Related]
17. LEKTI proteolytic processing in human primary keratinocytes, tissue distribution and defective expression in Netherton syndrome.
Bitoun E; Micheloni A; Lamant L; Bonnart C; Tartaglia-Polcini A; Cobbold C; Al Saati T; Mariotti F; Mazereeuw-Hautier J; Boralevi F; Hohl D; Harper J; Bodemer C; D'Alessio M; Hovnanian A
Hum Mol Genet; 2003 Oct; 12(19):2417-30. PubMed ID: 12915442
[TBL] [Abstract][Full Text] [Related]
18. A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation.
Borgoño CA; Michael IP; Komatsu N; Jayakumar A; Kapadia R; Clayman GL; Sotiropoulou G; Diamandis EP
J Biol Chem; 2007 Feb; 282(6):3640-52. PubMed ID: 17158887
[TBL] [Abstract][Full Text] [Related]
19. SPINK5 knockdown in organotypic human skin culture as a model system for Netherton syndrome: effect of genetic inhibition of serine proteases kallikrein 5 and kallikrein 7.
Wang S; Olt S; Schoefmann N; Stuetz A; Winiski A; Wolff-Winiski B
Exp Dermatol; 2014 Jul; 23(7):524-6. PubMed ID: 24848304
[TBL] [Abstract][Full Text] [Related]
20. Serine protease inhibitor lymphoepithelial Kazal type-related inhibitor tends to be decreased in atopic dermatitis.
Roedl D; Traidl-Hoffmann C; Ring J; Behrendt H; Braun-Falco M
J Eur Acad Dermatol Venereol; 2009 Nov; 23(11):1263-6. PubMed ID: 19522716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
